Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
Complementary Therapies in Medicine|April 13, 2013
Use of complementary and alternative medicine by children in Europe: published data and expert perspectivesTycho J Zuzak, Johanna Boňková, Domenico Careddu, et al.
Health Science Reports|January 29, 2026
Transferability of Real World Evidence to Support HTA Recommendations in Lower Income European CountriesZoltán Kaló, Guenka Petrova, Bertalan Németh, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|August 8, 2025
Introduction of Biopharmaceuticals in Europe: A Cross-Sectional Study of Early Diffusion Patterns and Data AvailabilityIvar Veszelei, Brian Godman, Katri Aaltonen, et al.
Expert Opinion on Pharmacotherapy|November 26, 2019
Pharmacotherapeutic interventions for bipolar disorder type II: addressing multiple symptoms and approaches with a particular emphasis on strategies in lower and middle-income countriesBrian Godman, Christoffel Grobler, Marianne Van-De-Lisle, et al.
Plos One|December 29, 2017
Policies for biosimilar uptake in Europe: An overviewEvelien Moorkens, Arnold G Vulto, Isabelle Huys, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|January 31, 2019
Proposal for a regulation on health technology assessment in Europe - opinions of policy makers, payers and academics from the field of HTAPatricia Vella Bonanno, Anna Bucsics, Steven Simoens, et al.
Biomed Research International|April 17, 2023
Corrigendum to "Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications"Brian Godman, Magdalene Wladysiuk, Stuart McTaggart, et al.
Biomed Research International|October 22, 2021
Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and ImplicationsBrian Godman, Magdalene Wladysiuk, Stuart McTaggart, et al.
Frontiers in Public Health|December 21, 2018
Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited BudgetsBrian Godman, Anna Bucsics, Patricia Vella Bonanno, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|February 4, 2021
Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implicationsBrian Godman, Andrew Hill, Steven Simoens, et al.
Pageof 11